In an effort to further their pharmaceutical research efforts, pharmaceutical companies across the globe are utilizing clinical documentation software programs to streamline the documentation and reduce Clinical Trial related costs and carbon footprints. Clinical documentation software programs are designed for the purpose of increasing productivity and decreasing the Clinical Study-related costs that are incurred by the pharmaceutical research and development activities for new pharmaceuticals or drugs.
Other measures that will be taken in implementing the strategies related to reducing clinical trial-related costs will be to consolidate the clinical documentation network and to enhance communication between the clinical study management systems and the clinical trial registry management. These methods will help to reduce the operational cost of the clinical trial by implementing the latest technology in the clinical trial operations. Ultimately, this will help to increase the number of successful clinical trials conducted by ensuring that the clinical trial protocol is followed appropriately and the trial as a whole is completed within the allocated budget.
For the last few years, researchers have been debating what constitutes a sustainable clinical trial. The first step to reducing the carbon footprint of clinical trials is to develop a tool to measure reliably the carbon footprint of trials and identify which elements of trials are carbon-heavy. For this reason, it was necessary to bring together the public health sector with commercial suppliers. The coalition has brought together a working party of triallists, clinicians, commercial companies, and others to work to reduce the carbon footprint of clinical trials to net zero. Tools to measure the carbon footprint are never perfect, but the tool that is being tested is expected to be reliable enough for measuring progress and benchmarking.
Another way that health researchers are hoping to improve the chances of positive clinical trial outcomes is by improving the design of the study itself and by introducing specific standards supporting clinical and non-clinical research processes from end to end. It is widely acknowledged that the use of case studies in health research can greatly improve the chances that a new treatment will have successful results. For this reason, it is often recommended that clinical trials be written with carefully controlled case studies in mind, with the use of appropriate placebo materials. While it may not always be possible to match placebo effects to patient characteristics, such as the severity of illness or other factors, it is believed that researchers can still create case studies that successfully control for such factors.